Beyond Statins: Therapies to Decrease Cardiovascular Risk

PCSK9 is an established target for cholesterol-lowering therapies. Further study of PCSK9 regulatory mechanisms may identify additional control points for pharmacological inhibition of PCSK9-mediated LDLR degradation. PCSK9 function could reflect ancient roles in the fasting-feeding cycle and in linking lipoprotein metabolism with innate immunity. Dr. Peter A. McCullough will discuss the regulatory function of PCSK9, as well as results from recent clinical trials on the efficacy and safety of PCSK9.

Target Audience

Cardiologists, Interventional Cardiologists, Interventional Radiologists, General Internists, Primary Care Physicians, Intensivists, General Surgeons, Gynecologists, Anesthesiologists, Emergency Medicine Physicians, Hospitalists and other interested healthcare providers.

Learning Objectives

  • Review global cardiovascular risk.
  • Demonstrate the regulatory function of PCSK9.
  • Synthesize the results of randomized trials with respect to efficacy and safety of PCSK9.
Additional information
Bibliography: 

Lagace, T. A. (2014). PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells. Current opinion in lipidology, 25(5), 387.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Nurse Practitioners
  • 1.00 General certificate of attendance
Course opens: 
05/01/2018
Course expires: 
05/01/2020

Peter A. McCullough, M.D., MPH, FACP, FACC, FCCP, FAHA, FNKF, FNLA, FCRSA
Vice Chief of Medicine
Baylor University Medical Center
Dallas, Texas
Principal Faculty in Internal Medicine
Texas A & M University Health Sciences Center
Dallas, Texas

Peter A. McCullough, M.D., has indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation or discussion.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
             
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Nurse Practitioners
  • 1.00 General certificate of attendance

Accreditation Period

Course opens: 
05/01/2018
Course expires: 
05/01/2020
Please login or register to take this course.

Required Hardware/software


This site is best viewed on the two most recent stable releases of the following browsers for all public pages:

PCs Running Windows

  • Google Chrome (Preferred): Download free web browser for PC, Mac, phone and tablet.
  • Internet Explorer (IE 11 and above recommended): You will be prompted to download videos before you are able to view. Click “download” to view video.  After a momentary pause, the recording will play.
  • Mozilla Firefox: You may be prompted under the “This Connection is Untrusted” screen to add “cmeonline.baptisthealth.net” and “cdn.baptisthealth.net” under “add exceptions”.

Apple Computers Running OSX

This site uses a responsive design, which allows the page layout of elements to change depending on the screen resolution. Certain functionality may change based on the screen resolution of smaller screens, such as the number of columns in a table.

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.